Kee Song Bio-Technology Holdings (ROCO:1258) Scaled Net Operating Assets : 0.64 (As of Mar. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Kee Song Bio-Technology Holdings's operating assets for the quarter that ended in Mar. 2023 was NT$1,923 Mil. Kee Song Bio-Technology Holdings's operating liabilities for the quarter that ended in Mar. 2023 was NT$433 Mil. Kee Song Bio-Technology Holdings's Total Assets for the quarter that ended in Dec. 2022 was NT$2,342 Mil. Therefore, Kee Song Bio-Technology Holdings's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2023 was 0.64.

Kee Song Bio-Technology Holdings Scaled Net Operating Assets Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings Scaled Net Operating Assets Chart

Kee Song Bio-Technology Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.83

0.71

0.63

0.59

0.71

Kee Song Bio-Technology Holdings Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.71	0.70	0.70	0.73	0.64

Competitive Comparison of Kee Song Bio-Technology Holdings's Scaled Net Operating Assets

For the Packaged Foods subindustry, Kee Song Bio-Technology Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kee Song Bio-Technology Holdings's Scaled Net Operating Assets Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kee Song Bio-Technology Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Kee Song Bio-Technology Holdings's Scaled Net Operating Assets falls into.

Kee Song Bio-Technology Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Kee Song Bio-Technology Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2022 )
=	(Operating Assets (A: Dec. 2022 )	-	Operating Liabilities (A: Dec. 2022 ))	/	Total Assets (A: Dec. 2021 )
=	(1999.15	-	472.811)	/	2141.568
=	0.71

where

	Operating Assets		(A: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2341.95	-	342.8
=	1999.15

	Operating Liabilities		(A: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1633.78	-	914.627	-	246.342
=	472.811

Kee Song Bio-Technology Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2023 )
=	(Operating Assets (Q: Mar. 2023 )	-	Operating Liabilities (Q: Mar. 2023 ))	/	Total Assets (Q: Dec. 2022 )
=	(1922.593	-	433.137)	/	2341.95
=	0.64

where

	Operating Assets		(Q: Mar. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2266.869	-	344.276
=	1922.593

	Operating Liabilities		(Q: Mar. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1509.079	-	865.974	-	209.968
=	433.137

Kee Song Bio-Technology Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104

Website

https://www.keesongbiotech.com

Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines